Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Cash from Financing Activities (2017 - 2024)

Historic Cash from Financing Activities for MedWellAI (MWAI) over the last 11 years, with Q2 2024 value amounting to -$50000.0.

  • MedWellAI's Cash from Financing Activities changed N/A to -$50000.0 in Q2 2024 from the same period last year, while for Mar 2025 it was -$50000.0, marking a year-over-year increase of 7411.34%. This contributed to the annual value of -$243150.0 for FY2024, which is 38630.0% down from last year.
  • As of Q2 2024, MedWellAI's Cash from Financing Activities stood at -$50000.0.
  • In the past 5 years, MedWellAI's Cash from Financing Activities ranged from a high of $8.1 million in Q2 2021 and a low of -$94620.0 during Q1 2024
  • Moreover, its 5-year median value for Cash from Financing Activities was $2962.0 (2020), whereas its average is $941021.0.
  • Within the past 5 years, the most significant YoY rise in MedWellAI's Cash from Financing Activities was 10698538.84% (2021), while the steepest drop was 10362.7% (2021).
  • Quarter analysis of 5 years shows MedWellAI's Cash from Financing Activities stood at $226816.0 in 2020, then plummeted by 100.73% to -$1659.0 in 2021, then soared by 37360.4% to $618150.0 in 2022, then plummeted by 108.33% to -$51500.0 in 2023, then rose by 2.91% to -$50000.0 in 2024.
  • Its Cash from Financing Activities stands at -$50000.0 for Q2 2024, versus -$94620.0 for Q1 2024 and -$51500.0 for Q4 2023.